A recent study evaluated the targeting accuracy for prostate cancer detection of a novel PSMA radiotracer, [64Cu]DOTA‐PSMA‐3Q, also exploring the potential for real‐time lesion verification during surgery using radiation‐guided technology.53 This evidence concerns the gene FOLH1 and Familial prostate cancer.